Future-proofing of Capa caprolactone monomer plant

11 June 2018

Perstorp has made progress in ‘future-proofing’ its Capa caprolactone monomer plant in Warrington, United Kingdom. The project was announced in August, 2017 with work beginning in the Q4 2017.

In 2011, Perstorp completed a major investment by building a second monomer line in Warrington, providing additional capacity and redundancy. The current project involves demolition of much of the original plant from 1996, followed by reconstruction from the ground up, to the latest standards. Demolition has been completed, with new equipment now in place. Production of caprolactone was not affected during the plant upgrade, which consists of installing a new peracetic acid still and new reactors. The project is expected to be complete in the second half of 2019.

Perstorp is increasing the capability of the plant to run with a higher capacity which will allow a larger output in the future. During changes in the market last year, Perstorp has made its spare capacity available to the market.

Safety of the plant is being further improved too. Introduction of state-of-the-art technology and information systems will mean that fewer manual interventions will be required in future.